Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Advisory committee meeting cancellation announced

April 8, 1998

Abbott discovers new agents for controlling synaptic transmission

April 8, 1998

Study shows Quadramet provides significant relief from bone pain

April 8, 1998

Warner-Lambert announces collaboration with Forest

April 8, 1998

Neurokinin A: a peptide with a potential role in the perception of pain

April 8, 1998

Pfizer NK1 antagonist and ondansetron provide synergistic antiemetic efficacy in clinical trials

April 7, 1998

First clinical trials performed with BMS-181885

April 7, 1998

Metabasis Therapeutics and Pfizer extend ARA research collaboration

April 7, 1998

Orphan Medical announces Xyrem clinical trial results

April 3, 1998

Centrally active adrenergic agents in development at Pierre Fabre

April 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...